QR Code

Obesity diminishes response to PD-1-based immunotherapies in renal cancer

Background Obesity is a major risk factor for renal cancer, yet our understanding of its effects on antitumor immunity and immunotherapy outcomes remains incomplete. Deciphering these associations is critical, given the growing clinical use of immune checkpoint inhibitors for metastatic disease and...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Peng Li, Amani Makkouk, Jennifer Gordetsky, Eddy Yang, Lewis Thomas, Yousef Zakharia, George J Weiner, Aliasger K Salem, Lakshminarayanan Nandagopal, Hesham Yasin, Rohan Garje, Shannon K Boi, Rachael M Orlandella, Justin Tyler Gibson, William James Turbitt, Gal Wald, Claire Buchta Rosean, Katlyn E Norris, Megan Bing, Laura Bertrand, Brett P Gross, Dmytro Starenki, Kristine I Farag, Robert E Sorge, James A Brown, David M Lubaroff, Rebecca C Arend, Kenneth Nepple, Tatiana T Marquez-Lago, Lyse A Norian
Hōputu: Artigo
Reo:Inglês
I whakaputaina: BMJ Publishing Group 2020-10-01
Rangatū:Journal for ImmunoTherapy of Cancer
Urunga tuihono:https://jitc.bmj.com/content/8/2/e000725.full
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite